
Title:
Rosacea
Text:
.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}For other uses, see Rosacea (disambiguation).



Medical condition.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}RosaceaOther namesAcne rosaceaRosacea over the cheeks and nose[1]Pronunciation/roʊˈzeɪʃ(i)ə/ SpecialtyDermatologySymptomsFacial redness, swelling, and small and superficial dilated blood vessels[2][3]ComplicationsRhinophyma[3]Usual onset30–50 years old[2]DurationLong term[2]TypesErythematotelengiectatic, papulopustular, phymatous, ocular[2]CausesUnknown[2]Risk factorsFamily history[3]Diagnostic methodBased on symptoms[2]Differential diagnosisAcne, perioral dermatitis, seborrhoeic dermatitis, dermatomyositis, lupus[2]MedicationAntibiotics either by mouth or applied to the skin[3]Frequency~5%[2]
Rosacea is a long-term skin condition that typically affects the face.[2][3] It results in redness, pimples, swelling, and small and superficial dilated blood vessels.[2] Often, the nose, cheeks, forehead, and chin are most involved.[3] A red, enlarged nose may occur in severe disease, a condition known as rhinophyma.[3]
The cause of rosacea is unknown.[2] Risk factors are believed to include a family history of the condition.[3] Factors that may potentially worsen the condition include heat, exercise, sunlight, cold, spicy food, alcohol, menopause, psychological stress, or steroid cream on the face.[3] Diagnosis is based on symptoms.[2]
While not curable, treatment usually improves symptoms.[3] Treatment is typically with metronidazole, doxycycline,  minocycline, or tetracycline.[4] When the eyes are affected, azithromycin eye drops may help.[5] Other treatments with tentative benefit include brimonidine cream, ivermectin cream, and isotretinoin.[4] Dermabrasion or laser surgery may also be used.[3] The use of sunscreen is typically recommended.[3]
Rosacea affects between 1% and 10% of people.[2] Those affected are most often 30 to 50 years old and female.[2] Caucasians are more frequently affected.[2] The condition was described in The Canterbury Tales in the 1300s, and possibly as early as the 200s BC by Theocritus.[6][7]

Contents

1 Signs and symptoms

1.1 Erythematotelangiectatic rosacea
1.2 Glandular rosacea


2 Cause

2.1 Cathelicidins
2.2 Demodex folliculitis and Demodex mites
2.3 Intestinal bacteria


3 Diagnosis

3.1 Classification
3.2 Variants


4 Treatment

4.1 Behavior
4.2 Medications
4.3 Laser


5 Outcomes
6 Epidemiology
7 See also
8 References
9 External links



Signs and symptoms[edit]
  Commonly affected zones[8]
Rosacea typically begins with reddening of the skin in symmetrical patches near the center of the face.[9] Common signs can depend on age and sex: flushing and red swollen patches are common in the young, small and visible dilated blood vessels in older individuals, and swelling of the nose is common in men.[9] Other signs include lumps on the skin (papules or pustules) and swelling of the face.[9] Many people experience stinging or burning pain and rarely itching.[9]
Skin problems tend to be aggravated by particular trigger factors, that differ for different people. Common triggers are ultraviolet light, heat, cold, or certain foods or beverages.[9]

Erythematotelangiectatic rosacea[edit]
Erythematotelangiectatic rosacea[10] rosacea (also known as "vascular rosacea"[10]) is characterized by prominent history of prolonged (over 10 minutes) flushing reaction to various stimuli, such as emotional stress, hot drinks, alcohol, spicy foods, exercise, cold or hot weather, or hot baths and showers.[11]

Glandular rosacea[edit]
In glandular rosacea, men with thick sebaceous skin predominate, a disease in which the papules are edematous, and the pustules are often 0.5 to 1.0 cm in size, with nodulocystic lesions often present.[11]

Cause[edit]
  Topical steroid-induced rosacea (left); after steroid withdrawal and photobiomodulation therapy (right)
The exact cause of rosacea is unknown.[2] Triggers that cause episodes of flushing and blushing play a part in its development. Exposure to temperature extremes, strenuous exercise, heat from sunlight, severe sunburn, stress, anxiety, cold wind, and moving to a warm or hot environment from a cold one, such as heated shops and offices during the winter, can each cause the face to become flushed.[2] Certain foods and drinks can also trigger flushing, such as alcohol, foods and beverages containing caffeine (especially hot tea and coffee), foods high in histamines, and spicy foods.[12]
Medications and topical irritants have also been known to trigger rosacea flares. Some acne and wrinkle treatments reported to cause rosacea include microdermabrasion and chemical peels, as well as high dosages of isotretinoin, benzoyl peroxide, and tretinoin.
Steroid-induced rosacea is caused by the use of topical steroids.[13] These steroids are often prescribed for seborrheic dermatitis. Dosage should be slowly decreased and not immediately stopped to avoid a flare-up.

Cathelicidins[edit]
In 2007, Richard Gallo and colleagues noticed that patients with rosacea had high levels of the antimicrobial peptide cathelicidin[14] and elevated levels of stratum corneum tryptic enzymes (SCTEs). Antibiotics have been used in the past to treat rosacea, but they may only work because they inhibit some SCTEs.[14]

Demodex folliculitis and Demodex mites[edit]
Studies of rosacea and Demodex mites have revealed that some people with rosacea have increased numbers of the mite,[12] especially those with steroid-induced rosacea. Demodex folliculitis (demodicidosis, also known as "mange" in animals) is a condition that may have a "rosacea-like" appearance.[15]
A 2007, National Rosacea Society-funded study demonstrated that Demodex folliculorum mites may be a cause or exacerbating factor in rosacea.[16] The researchers identified Bacillus oleronius as distinct bacteria associated with Demodex mites. When analyzing blood samples using a peripheral blood mononuclear cell proliferation assay, they discovered that B. oleronius stimulated an immune system response in 79 percent of 22 patients with subtype 2 (papulopustular) rosacea, compared with only 29% of 17 subjects without the disorder. They concluded, "The immune response results in inflammation, as evident in the papules (bumps) and pustules (pimples) of subtype 2 rosacea. This suggests that the B. oleronius bacteria found in the mites could be responsible for the inflammation associated with the condition."[16]

Intestinal bacteria[edit]
Small intestinal bacterial overgrowth (SIBO) was demonstrated to have greater prevalence in rosacea patients and treating it with locally acting antibiotics led to rosacea lesion improvement in two studies. Conversely in rosacea patients who were SIBO negative, antibiotic therapy had no effect.[17] The effectiveness of treating SIBO in rosacea patients may suggest that gut bacteria play a role in the pathogenesis of rosacea lesions.

Diagnosis[edit]
Most people with rosacea have only mild redness and are never formally diagnosed or treated.  No test for rosacea is known. In many cases, simple visual inspection by a trained health-care professional is sufficient for diagnosis.  In other cases, particularly when pimples or redness on less-common parts of the face is present, a trial of common treatments is useful for confirming a suspected diagnosis. The disorder can be confused or co-exist with acne vulgaris or seborrheic dermatitis.  The presence of a rash on the scalp or ears suggests a different or co-existing diagnosis because rosacea is primarily a facial diagnosis, although it may occasionally appear in these other areas.

Classification[edit]
  Rosacea on the face
  Micrograph showing rosacea as enlarged, dilated capillaries and venules located in the upper dermis, angulated telangiectasias, perivascular and perifollicular lymphocytic infiltration, and superficial dermal edema.[18]
Four rosacea subtypes exist,[19] and a patient may have more than one subtype:[20]: 176 

Erythematotelangiectatic rosacea exhibits permanent redness (erythema) with a tendency to flush and blush easily.[12] Also small, widened blood vessels visible near the surface of the skin (telangiectasias) and possibly intense burning, stinging, and itching are common.[12] People with this type often have sensitive skin. Skin can also become very dry and flaky. In addition to the face, signs can also appear on the ears, neck, chest, upper back, and scalp.[21]
Papulopustular rosacea presents with some permanent redness with red bumps (papules); some pus-filled pustules can last 1–4 days or longer. This subtype is often confused with acne.
Phymatous rosacea is most commonly associated with rhinophyma, an enlargement of the nose. Signs include thickening skin, irregular surface nodularities, and enlargement. Phymatous rosacea can also affect the chin (gnathophyma), forehead (metophyma), cheeks, eyelids (blepharophyma), and ears (otophyma).[22] Telangiectasias may be present.
In ocular rosacea, affected eyes and eyelids may appear red due to telangiectasias and inflammation, and may feel dry, irritated, or gritty. Other symptoms include foreign-body sensations, itching,  burning, stinging, and sensitivity to light.[23] Eyes can become more susceptible to infection. About half of the people with subtypes 1–3 also have eye symptoms.  Blurry vision and vision loss can occur if the cornea is affected.[23]
Variants[edit]
Variants of rosacea include:[24]: 689 

Pyoderma faciale, also known as rosacea fulminans,[24] is a conglobate, nodular disease that arises abruptly on the face.[10][24]
Rosacea conglobata is a severe rosacea that can mimic acne conglobata, with hemorrhagic nodular abscesses and indurated plaques.[24]
Phymatous rosacea is a cutaneous condition characterized by overgrowth of sebaceous glands.[10]  Phyma is Greek for swelling, mass, or bulb, and these can occur on the face and ears.[24]: 693 
Treatment[edit]
The type of rosacea a person has informs the choice of treatment.[25] Mild cases are often not treated at all, or are simply covered up with normal cosmetics.
Therapy for the treatment of rosacea is not curative, and is best measured in terms of reduction in the amount of facial redness and inflammatory lesions, a decrease in the number, duration, and intensity of flares, and concomitant symptoms of itching, burning, and tenderness. The two primary modalities of rosacea treatment are topical and oral antibiotic agents.[26] Laser therapy has also been classified as a form of treatment.[26] While medications often produce a temporary remission of redness within a few weeks, the redness typically returns shortly after treatment is suspended.  Long-term treatment, usually 1–2 years, may result in permanent control of the condition for some patients.[26][27] Lifelong treatment is often necessary, although some cases resolve after a while and go into a permanent remission.[27]  Other cases, if left untreated, worsen over time.[28]

Behavior[edit]
Avoiding triggers that worsen the condition can help reduce the onset of rosacea, but alone will not normally lead to remission except in mild cases. Keeping a journal is sometimes recommended to help identify and reduce food and beverage triggers.
Because sunlight is a common trigger, avoiding excessive exposure to the sun is widely recommended.  Some people with rosacea benefit from daily use of a sunscreen; others opt for wearing hats with broad brims. Like sunlight, emotional stress can also trigger rosacea. People who develop infections of the eyelids must practice frequent eyelid hygiene.
Managing pretrigger events such as prolonged exposure to cool environments can directly influence warm-room flushing.[29]

Medications[edit]
Medications with good evidence include topical ivermectin and azelaic acid creams and brimonidine, and doxycycline and isotretinoin by mouth.[30] Lesser evidence supports topical metronidazole cream and tetracycline by mouth.[30]
Metronidazole is thought to act through anti-inflammatory mechanisms, while azelaic acid is thought to decrease cathelicidin production. Oral antibiotics of the tetracycline class such as doxycycline, minocycline, and oxytetracycline are also commonly used and thought to reduce papulopustular lesions through anti-inflammatory actions rather than through their antibacterial capabilities.[12]
Using alpha-hydroxy acid peels may help relieve redness caused by irritation, and reduce papules and pustules associated with rosacea.[31] Oral antibiotics may help to relieve symptoms of ocular rosacea. If papules and pustules persist, then sometimes isotretinoin can be prescribed.[32] The flushing and blushing that typically accompany rosacea are typically treated with the topical application of alpha agonists such as brimonidine and less commonly oxymetazoline or xylometazoline.[12]
A review found that ivermectin was more effective than alternatives for treatment of papulopustular acne rosacea.[33][34] An ivermectin cream has been approved by the FDA, as well as in Europe, for the treatment of inflammatory lesions of rosacea. The treatment is based upon the hypothesis that parasitic mites of the genus Demodex play a role in rosacea.[35] In a clinical study, ivermectin reduced lesions by 83% over 4 months, as compared to 74% under a metronidazole standard therapy.[36]

Laser[edit]
Evidence for the use of laser and intense pulsed-light therapy in rosacea is poor.[37]

Outcomes[edit]
The highly visible nature of rosacea symptomps are often psychologically challenging for those affected. People with rosacea can experience issues with self-esteem, socializing, and changes to their thoughts, feelings, and coping mechanisms.[9]

Epidemiology[edit]
Rosaceae affects around 5% of people worldwide.[9] Incidence varies by ethnicity, and is particularly prevalent in those with celtic heritage.[9] Men are women are equally like to develop rosacea.[9]

See also[edit]
.mw-parser-output .portalbox{float:right;border:solid #aaa 1px;padding:0}.mw-parser-output .portalbox.tleft{margin:0.5em 1em 0.5em 0}.mw-parser-output .portalbox.tright{margin:0.5em 0 0.5em 1em}.mw-parser-output .portalbox>ul{display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold}.mw-parser-output .portalbox>ul>li{display:table-row}.mw-parser-output .portalbox>ul>li>span:first-child{display:table-cell;padding:0.2em;vertical-align:middle;text-align:center}.mw-parser-output .portalbox>ul>li>span:last-child{display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle}

Medicine portal
Seborrheic dermatitis
Keratosis pilaris

References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}Sand, M; Sand, D; Thrandorf, C; Paech, V; Altmeyer, P; Bechara, FG (4 June 2010). "Cutaneous lesions of the nose". Head & Face Medicine. 6: 7. doi:10.1186/1746-160X-6-7. PMC 2903548. PMID 20525327.

^ Jump up to: a b c d e f g h i j k l m n o p q Tüzün Y, Wolf R, Kutlubay Z, Karakuş O, Engin B (February 2014). "Rosacea and rhinophyma". Clinics in Dermatology. 32 (1): 35–46. doi:10.1016/j.clindermatol.2013.05.024. PMID 24314376.

^ Jump up to: a b c d e f g h i j k l "Questions and Answers about Rosacea". www.niams.nih.gov. April 2016. Archived from the original on 13 May 2017. Retrieved 5 June 2017.

^ Jump up to: a b van Zuuren, EJ; Fedorowicz, Z (September 2015). "Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments". The British Journal of Dermatology. 173 (3): 651–62. doi:10.1111/bjd.13956. PMID 26099423. S2CID 41303286.

^ "Rosacea First choice treatments". Prescrire International. 182: 126–128. May 2017. Archived from the original on 10 September 2017.

^ Zouboulis, Christos C.; Katsambas, Andreas D.; Kligman, Albert M. (2014). Pathogenesis and Treatment of Acne and Rosacea. Springer. p. XXV. ISBN 978-3-540-69375-8. Archived from the original on 10 September 2017.

^ Schachner, Lawrence A.; Hansen, Ronald C. (2011). Pediatric Dermatology E-Book. Elsevier Health Sciences. p. 827. ISBN 978-0-7234-3665-2. Archived from the original on 10 September 2017.

^  name="JAmAcadDermatol2004-Wilkin">Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F (2004). "Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea" (PDF). J Am Acad Dermatol. 50 (6): 907–12. doi:10.1016/j.jaad.2004.01.048. PMID 15153893. Archived from the original (PDF reprint) on 27 February 2007.

^ Jump up to: a b c d e f g h i Buddenkotte J, Steinhoff M (2018). "Recent advances in understanding and managing rosacea". F1000Res. 7. doi:10.12688/f1000research.16537.1. PMC 6281021. PMID 30631431.

^ Jump up to: a b c d Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.

^ Jump up to: a b James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. Page 245. ISBN 0-7216-2921-0.

^ Jump up to: a b c d e f Del Rosso JQ (October 2014). "Management of cutaneous rosacea: emphasis on new medical therapies". Expert Opin Pharmacother. 15 (14): 2029–38. doi:10.1517/14656566.2014.945423. PMID 25186025.

^ "Rosacea". DermNet, New Zealand Dermatological Society. Archived from the original on 7 December 2010. Retrieved 3 February 2011.

^ Jump up to: a b Kenshi Yamasaki; Anna Di Nardo; Antonella Bardan; Masamoto Murakami; Takaaki Ohtake; Alvin Coda; Robert A Dorschner; Chrystelle Bonnart; Pascal Descargues; Alain Hovnanian; Vera B Morhenn; Richard L Gallo (August 2007). "Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea". Nature Medicine. 13 (8): 975–80. doi:10.1038/nm1616. PMID 17676051. S2CID 23470611.

^ Baima B, Sticherling M (2002). "Demodicidosis revisited". Acta Dermato-Venereologica. 82 (1): 3–6. doi:10.1080/000155502753600795. PMID 12013194.

^ Jump up to: a b Lacey N, Delaney S, Kavanagh K, Powell FC (2007). "Mite-related bacterial antigens stimulate inflammatory cells in rosacea" (PDF). British Journal of Dermatology. 157 (3): 474–481. doi:10.1111/j.1365-2133.2007.08028.x. PMID 17596156. S2CID 8057780.

^ Elizabeth Lazaridou; Christina Giannopoulou; Christina Fotiadou; Eustratios Vakirlis; Anastasia Trigoni; Demetris Ioannides (November 2010). "The potential role of microorganisms in the development of rosacea". JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 9 (1): 21–25. doi:10.1111/j.1610-0387.2010.07513.x. PMID 21059171. S2CID 23494211.

^ Celiker, Hande; Toker, Ebru; Ergun, Tulin; Cinel, Leyla (2017). "An unusual presentation of ocular rosacea". Arquivos Brasileiros de Oftalmologia. 80 (6): 396–398. doi:10.5935/0004-2749.20170097. ISSN 0004-2749. PMID 29267579.

^ Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F (2004). "Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea" (PDF). J Am Acad Dermatol. 50 (6): 907–12. doi:10.1016/j.jaad.2004.01.048. PMID 15153893. Archived from the original (PDF reprint) on 27 February 2007.

^ Marks, James G; Miller, Jeffery (2006). Lookingbill and Marks' Principles of Dermatology (4th ed.). Elsevier Inc. ISBN 1-4160-3185-5.

^ "What Rosacea Looks Like". Archived from the original on 4 February 2013. Retrieved 30 January 2013.

^ Jansen T, Plewig G (1998). "Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities". Facial Plast Surg. 14 (4): 241–53. doi:10.1055/s-2008-1064456. PMID 11816064.

^ Jump up to: a b Vieira AC, Mannis MJ (December 2013). "Ocular rosacea: common and commonly missed". J Am Acad Dermatol. 69 (6 (Suppl 1)): S36–41. doi:10.1016/j.jaad.2013.04.042. PMID 24229635.

^ Jump up to: a b c d e Freedberg, et al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0-07-138076-0.

^ van Zuuren, EJ; Fedorowicz, Z; Tan, J; van der Linden, MMD; Arents, BWM; Carter, B; Charland, L (July 2019). "Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments". The British Journal of Dermatology. 181 (1): 65–79. doi:10.1111/bjd.17590. PMC 6850438. PMID 30585305.

^ Jump up to: a b c Noah Scheinfeld; Thomas Berk (January 2010). "A Review of the Diagnosis and Treatment of Rosacea". Postgraduate Medicine. 122 (1): 139–43. doi:10.3810/pgm.2010.01.2107. PMID 20107297. S2CID 22914205. Archived from the original on 5 January 2011.

^ Jump up to: a b Culp B, Scheinfeld N (January 2009). "Rosacea: a review". P&T. 34 (1): 38–45. PMC 2700634. PMID 19562004.

^ Huynh, Tu T. "Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life". American Health & Drug Benefits. 6 (6): 348–354. ISSN 1942-2962. PMC 4031723. PMID 24991368.

^ Dahl, Colin (2008). A Practical Understanding of Rosacea – part one. Australian Sciences. Archived from the original on 21 March 2008. Retrieved 27 August 2008.

^ Jump up to: a b van Zuuren, EJ; Fedorowicz, Z; Carter, B; van der Linden, MM; Charland, L (28 April 2015). "Interventions for rosacea". The Cochrane Database of Systematic Reviews. 4 (4): CD003262. doi:10.1002/14651858.CD003262.pub5. PMC 6481562. PMID 25919144.

^ Tung, RC; Bergfeld, WF; Vidimos, AT; Remzi, BK (2000). "alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management". American Journal of Clinical Dermatology. 1 (2): 81–8. doi:10.2165/00128071-200001020-00002. PMID 11702315. S2CID 58337540.

^ Hoting E, Paul E, Plewig G (December 1986). "Treatment of rosacea with isotretinoin". Int J Dermatol. 25 (10): 660–3. doi:10.1111/j.1365-4362.1986.tb04533.x. PMID 2948928. S2CID 22421145.

^ Husein-ElAhmed H, Steinhoff M (January 2020). "Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta-analysis". Dermatol Ther. 33 (1): e13203. doi:10.1111/dth.13203. PMID 31863543. S2CID 209433363.

^ Siddiqui K, Stein Gold L, Gill J (2016). "The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis". SpringerPlus. 5 (1): 1151. doi:10.1186/s40064-016-2819-8. PMC 4956638. PMID 27504249.

^ Moran EM, Foley R, Powell FC (2017). "Demodex and rosacea revisited". Clin. Dermatol. 35 (2): 195–200. doi:10.1016/j.clindermatol.2016.10.014. PMID 28274359.

^ "Galderma Receives FDA Approval of Soolantra (Ivermectin) Cream for Rosacea". drugs.com. Archived from the original on 22 January 2015."

^ van Zuuren, EJ; Fedorowicz, Z; Carter, B; van der Linden, MM; Charland, L (28 April 2015). "Interventions for rosacea". The Cochrane Database of Systematic Reviews (4): CD003262. doi:10.1002/14651858.CD003262.pub5. PMC 6481562. PMID 25919144.


External links[edit]
.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}ClassificationDICD-10: L71ICD-9-CM: 695.3MeSH: D012393DiseasesDB: 96External resourcesMedlinePlus: 000879eMedicine: derm/377



Wikibooks has a book on the topic of: Rosacea




Wikimedia Commons has media related to Rosacea (disease).

Rosacea at Curlie
Rosacea photo library at Dermnet
Questions and Answers about Rosacea, from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases
show.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vteDiseases of the skin and appendages by morphologyGrowthsEpidermal
Wart
Callus
Seborrheic keratosis
Acrochordon
Molluscum contagiosum
Actinic keratosis
Squamous-cell carcinoma
Basal-cell carcinoma
Merkel-cell carcinoma
Nevus sebaceous
Trichoepithelioma
Pigmented
Freckles
Lentigo
Melasma
Nevus
Melanoma
Dermal andsubcutaneous
Epidermal inclusion cyst
Hemangioma
Dermatofibroma (benign fibrous histiocytoma)
Keloid
Lipoma
Neurofibroma
Xanthoma
Kaposi's sarcoma
Infantile digital fibromatosis
Granular cell tumor
Leiomyoma
Lymphangioma circumscriptum
Myxoid cyst
RashesWith epidermal involvementEczematous
Contact dermatitis
Atopic dermatitis
Seborrheic dermatitis
Stasis dermatitis
Lichen simplex chronicus
Darier's disease
Glucagonoma syndrome
Langerhans cell histiocytosis
Lichen sclerosus
Pemphigus foliaceus
Wiskott–Aldrich syndrome
Zinc deficiency
Scaling
Psoriasis
Tinea (Corporis
Cruris
Pedis
Manuum
Faciei)
Pityriasis rosea
Secondary syphilis
Mycosis fungoides
Systemic lupus erythematosus
Pityriasis rubra pilaris
Parapsoriasis
Ichthyosis
Blistering
Herpes simplex
Herpes zoster
Varicella
Bullous impetigo
Acute contact dermatitis
Pemphigus vulgaris
Bullous pemphigoid
Dermatitis herpetiformis
Porphyria cutanea tarda
Epidermolysis bullosa simplex
Papular
Scabies
Insect bite reactions
Lichen planus
Miliaria
Keratosis pilaris
Lichen spinulosus
Transient acantholytic dermatosis
Lichen nitidus
Pityriasis lichenoides et varioliformis acuta
Pustular
Acne vulgaris
Acne rosacea
Folliculitis
Impetigo
Candidiasis
Gonococcemia
Dermatophyte
Coccidioidomycosis
Subcorneal pustular dermatosis
Hypopigmented
Tinea versicolor
Vitiligo
Pityriasis alba
Postinflammatory hyperpigmentation
Tuberous sclerosis
Idiopathic guttate hypomelanosis
Leprosy
Hypopigmented mycosis fungoides
Without epidermal involvementRedBlanchable ErythemaGeneralized
Drug eruptions
Viral exanthems
Toxic erythema
Systemic lupus erythematosus
Localized
Cellulitis
Abscess
Boil
Erythema nodosum
Carcinoid syndrome
Fixed drug eruption
Specialized
Urticaria
Erythema (Multiforme
Migrans
Gyratum repens
Annulare centrifugum
Ab igne)
Nonblanchable PurpuraMacular
Thrombocytopenic purpura
Actinic/solar purpura
Papular
Disseminated intravascular coagulation
Vasculitis
Indurated
Scleroderma/morphea
Granuloma annulare
Lichen sclerosis et atrophicus
Necrobiosis lipoidica
Miscellaneous disordersUlcers

Hair
Telogen effluvium
Androgenic alopecia
Alopecia areata
Systemic lupus erythematosus
Tinea capitis
Loose anagen syndrome
Lichen planopilaris
Folliculitis decalvans
Acne keloidalis nuchae
Nail
Onychomycosis
Psoriasis
Paronychia
Ingrown nail
Mucous membrane
Aphthous stomatitis
Oral candidiasis
Lichen planus
Leukoplakia
Pemphigus vulgaris
Mucous membrane pemphigoid
Cicatricial pemphigoid
Herpesvirus
Coxsackievirus
Syphilis
Systemic histoplasmosis
Squamous-cell carcinoma

showvteDisorders of skin appendagesNail
thickness: Onychogryphosis
Onychauxis
color: Beau's lines
Yellow nail syndrome
Leukonychia
Azure lunula
shape: Koilonychia
Nail clubbing
behavior: Onychotillomania
Onychophagia
other: Ingrown nail
Anonychia
ungrouped: Paronychia
Acute
Chronic
Chevron nail
Congenital onychodysplasia of the index fingers
Green nails
Half and half nails
Hangnail
Hapalonychia
Hook nail
Ingrown nail
Lichen planus of the nails
Longitudinal erythronychia
Malalignment of the nail plate
Median nail dystrophy
Mees' lines
Melanonychia
Muehrcke's lines
Nail–patella syndrome
Onychoatrophy
Onycholysis
Onychomadesis
Onychomatricoma
Onychomycosis
Onychophosis
Onychoptosis defluvium
Onychorrhexis
Onychoschizia
Platonychia
Pincer nails
Plummer's nail
Psoriatic nails
Pterygium inversum unguis
Pterygium unguis
Purpura of the nail bed
Racquet nail
Red lunulae
Shell nail syndrome
Splinter hemorrhage
Spotted lunulae
Staining of the nail plate
Stippled nails
Subungual hematoma
Terry's nails
Twenty-nail dystrophy
HairHair loss/Baldness
noncicatricial alopecia: Alopecia
areata
totalis
universalis
Ophiasis
Androgenic alopecia (male-pattern baldness)
Hypotrichosis
Telogen effluvium
Traction alopecia
Lichen planopilaris
Trichorrhexis nodosa
Alopecia neoplastica
Anagen effluvium
Alopecia mucinosa
cicatricial alopecia: Pseudopelade of Brocq
Central centrifugal cicatricial alopecia
Pressure alopecia
Traumatic alopecia
Tumor alopecia
Hot comb alopecia
Perifolliculitis capitis abscedens et suffodiens
Graham-Little syndrome
Folliculitis decalvans
ungrouped: Triangular alopecia
Frontal fibrosing alopecia
Marie Unna hereditary hypotrichosis
Hypertrichosis
Hirsutism
Acquired
localised
generalised
patterned
Congenital
generalised
localised
X-linked
Prepubertal
AcneiformeruptionAcne
Acne vulgaris
Acne conglobata
Acne miliaris necrotica
Tropical acne
Infantile acne/Neonatal acne
Excoriated acne
Acne fulminans
Acne medicamentosa (e.g., steroid acne)
Halogen acne
Iododerma
Bromoderma
Chloracne
Oil acne
Tar acne
Acne cosmetica
Occupational acne
Acne aestivalis
Acne keloidalis nuchae
Acne mechanica
Acne with facial edema
Pomade acne
Acne necrotica
Blackhead
Lupus miliaris disseminatus faciei
Rosacea
Perioral dermatitis
Granulomatous perioral dermatitis
Phymatous rosacea
Rhinophyma
Blepharophyma
Gnathophyma
Metophyma
Otophyma
Papulopustular rosacea
Lupoid rosacea
Erythrotelangiectatic rosacea
Glandular rosacea
Gram-negative rosacea
Steroid rosacea
Ocular rosacea
Persistent edema of rosacea
Rosacea conglobata
variants
Periorificial dermatitis
Pyoderma faciale
Ungrouped
Granulomatous facial dermatitis
Idiopathic facial aseptic granuloma
Periorbital dermatitis
SAPHO syndrome
Follicular cysts
"Sebaceous cyst"
Epidermoid cyst
Trichilemmal cyst
Steatocystoma
simplex
multiplex
Milia
Inflammation
Folliculitis
Folliculitis nares perforans
Tufted folliculitis
Pseudofolliculitis barbae
Hidradenitis
Hidradenitis suppurativa
Recurrent palmoplantar hidradenitis
Neutrophilic eccrine hidradenitis
Ungrouped
Acrokeratosis paraneoplastica of Bazex
Acroosteolysis
Bubble hair deformity
Disseminate and recurrent infundibulofolliculitis
Erosive pustular dermatitis of the scalp
Erythromelanosis follicularis faciei et colli
Hair casts
Hair follicle nevus
Intermittent hair–follicle dystrophy
Keratosis pilaris atropicans
Kinking hair
Koenen's tumor
Lichen planopilaris
Lichen spinulosus
Loose anagen syndrome
Menkes kinky hair syndrome
Monilethrix
Parakeratosis pustulosa
Pili (Pili annulati
Pili bifurcati
Pili multigemini
Pili pseudoannulati
Pili torti)
Pityriasis amiantacea
Plica neuropathica
Poliosis
Rubinstein–Taybi syndrome
Setleis syndrome
Traumatic anserine folliculosis
Trichomegaly
Trichomycosis axillaris
Trichorrhexis (Trichorrhexis invaginata
Trichorrhexis nodosa)
Trichostasis spinulosa
Uncombable hair syndrome
Wooly hair nevus
SweatglandsEccrine
Miliaria
Colloid milium
Miliaria crystalline
Miliaria profunda
Miliaria pustulosa
Miliaria rubra
Occlusion miliaria
Postmiliarial hypohidrosis
Granulosis rubra nasi
Ross’ syndrome
Anhidrosis
Hyperhidrosis
Generalized
Gustatory
Palmoplantar
Apocrine
Body odor
Chromhidrosis
Fox–Fordyce disease
Sebaceous
Sebaceous hyperplasia

Authority control: National libraries  
France (data)
United States






